Pioneer Investment Management Inc. lowered its position in Humana Inc. (NYSE:HUM) by 7.4% during the second quarter, Holdings Channel reports. The institutional investor owned 437,224 shares of the insurance provider’s stock after selling 34,870 shares during the period. Pioneer Investment Management Inc.’s holdings in Humana were worth $105,205,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. boosted its position in shares of Humana by 2,281.7% in the first quarter. BlackRock Inc. now owns 12,387,144 shares of the insurance provider’s stock worth $2,553,487,000 after buying an additional 11,867,056 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Humana by 3.6% in the first quarter. Vanguard Group Inc. now owns 9,734,767 shares of the insurance provider’s stock worth $2,006,725,000 after buying an additional 339,620 shares in the last quarter. State Street Corp boosted its position in shares of Humana by 1.4% in the first quarter. State Street Corp now owns 6,274,811 shares of the insurance provider’s stock worth $1,293,487,000 after buying an additional 84,716 shares in the last quarter. FMR LLC boosted its position in shares of Humana by 57.9% in the first quarter. FMR LLC now owns 5,050,853 shares of the insurance provider’s stock worth $1,041,184,000 after buying an additional 1,851,197 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its position in shares of Humana by 84.3% in the first quarter. Renaissance Technologies LLC now owns 2,691,700 shares of the insurance provider’s stock worth $554,867,000 after buying an additional 1,231,400 shares in the last quarter. 99.66% of the stock is currently owned by institutional investors.

Humana Inc. (NYSE:HUM) opened at 249.62 on Tuesday. The firm has a market capitalization of $36.07 billion, a price-to-earnings ratio of 20.53 and a beta of 0.91. The stock’s 50 day moving average is $236.19 and its 200 day moving average is $220.68. Humana Inc. has a 1-year low of $163.50 and a 1-year high of $251.79.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, beating analysts’ consensus estimates of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The company had revenue of $13.53 billion for the quarter, compared to analyst estimates of $13.61 billion. During the same period last year, the firm earned $2.30 earnings per share. Analysts predict that Humana Inc. will post $11.45 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another publication, it was illegally copied and reposted in violation of United States & international trademark and copyright laws. The legal version of this news story can be viewed at https://www.dailypolitical.com/2017/08/08/humana-inc-hum-stake-lowered-by-pioneer-investment-management-inc.html.

Several equities research analysts recently commented on the stock. Zacks Investment Research cut shares of Humana from a “buy” rating to a “hold” rating in a research report on Monday, April 24th. Cowen and Company reaffirmed a “buy” rating and issued a $230.00 price objective on shares of Humana in a research report on Friday, July 14th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $223.00 price objective (up from $200.00) on shares of Humana in a research report on Thursday, August 3rd. Jefferies Group LLC reaffirmed a “hold” rating and issued a $257.00 price objective on shares of Humana in a research report on Friday. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and issued a $246.00 price objective on shares of Humana in a research report on Friday, July 14th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and twelve have given a buy rating to the stock. Humana currently has an average rating of “Hold” and a consensus price target of $243.00.

In related news, VP Heidi S. Margulis sold 1,500 shares of the firm’s stock in a transaction dated Friday, May 26th. The shares were sold at an average price of $231.96, for a total transaction of $347,940.00. Following the transaction, the vice president now directly owns 8,150 shares of the company’s stock, valued at $1,890,474. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Brian P. Leclaire sold 4,971 shares of the firm’s stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the transaction, the senior vice president now directly owns 14,258 shares in the company, valued at $3,421,920. The disclosure for this sale can be found here. 0.80% of the stock is owned by company insiders.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.